Atlas Trials

Exploring the Frontiers of Neoadjuvant Therapy for Lung Cancer: a Prospective Observational Real-world Study

Clinical trial NCT06216782 · RECRUITING

Trial details

NCT number
NCT06216782
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Status
RECRUITING
Study type
OBSERVATIONAL
Lung Cancer
Start date
2023-12-16
Primary completion
2033-12-30
Enrollment
2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.